1998
DOI: 10.1021/jm9704917
|View full text |Cite
|
Sign up to set email alerts
|

Novel Synthetic Inhibitors of Selectin-Mediated Cell Adhesion:  Synthesis of 1,6-Bis[3-(3-carboxymethylphenyl)-4-(2-α-d-mannopyranosyloxy)phenyl]hexane (TBC1269)

Abstract: Reports of a high-affinity ligand for E-selectin, sialyl di-Lewis(x) (sLe(x)Le(x), 1), motivated us to incorporate modifications to previously reported biphenyl-based inhibitors that would provide additional interactions with the protein. These compounds were assayed for the ability to inhibit the binding of sialyl Lewis(x) (sLe(x), 2) bearing HL-60 cells to E-, P-, and L-selectin fusion proteins. We report that dimeric or trimeric compounds containing multiple components of simple nonoligosaccharide selectin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
88
0
1

Year Published

2001
2001
2020
2020

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 126 publications
(94 citation statements)
references
References 32 publications
5
88
0
1
Order By: Relevance
“…The specific inhibitors of p38 MAPK (SB-202190) and p42/44 MAPK (PD98059) were purchased from Biomol Research Laboratories (Plymouth Meeting, PA). The sialyl diLewis x mimetic inhibitor TBC 1269 (1,6-Bis[3-(3-carboxymethylphenyl)-4-(2-␣-D-mannopyranosyloxy)phenyl]hexane) and the control compound TBC 1900 were gifts from Texas Biotechnology (Houston, TX) (26). PEconjugated anti-human Mac-1 (2LPM19c) was purchased from DAKO (Carpinteria, CA).…”
Section: Agonists Inhibitors and Absmentioning
confidence: 99%
“…The specific inhibitors of p38 MAPK (SB-202190) and p42/44 MAPK (PD98059) were purchased from Biomol Research Laboratories (Plymouth Meeting, PA). The sialyl diLewis x mimetic inhibitor TBC 1269 (1,6-Bis[3-(3-carboxymethylphenyl)-4-(2-␣-D-mannopyranosyloxy)phenyl]hexane) and the control compound TBC 1900 were gifts from Texas Biotechnology (Houston, TX) (26). PEconjugated anti-human Mac-1 (2LPM19c) was purchased from DAKO (Carpinteria, CA).…”
Section: Agonists Inhibitors and Absmentioning
confidence: 99%
“…16,17 This inhibitor inhibits binding of E-, P-, and L-selectins to sLe x , with inhibitory concentration 50 (IC 50 ) values of 105 µM, 17 µM, and 87 µM, respectively. 16 Results of safety and efficacy studies indicate that TBC1269 does not have cytotoxic effects. 16 TBC1269 has been used in humans with allergic asthma.…”
Section: Preparation Of Tbc1269-tbc1269mentioning
confidence: 99%
“…16 Results of safety and efficacy studies indicate that TBC1269 does not have cytotoxic effects. 16 TBC1269 has been used in humans with allergic asthma. Treatment resulted in a reduction in number of eosinophils in sputum and improvement of the late bronchoconstriction reaction.…”
Section: Preparation Of Tbc1269-tbc1269mentioning
confidence: 99%
See 1 more Smart Citation
“…binding of sialyl Lewis X to selectins in vitro. [22][23][24][25] This mimetic has been used in vivo in clinical studies for use in the treatment of humans with allergic asthma. It is effective for preventing neutrophil-mediated reperfusion injury in rat liver 23 and in reducing the initial cellular response to pulmonary antigen in a sheep model of allergic bronchoconstriction.…”
mentioning
confidence: 99%